Can-Fite BioPharma Ltd. (CANF) Net income 2016–2025
Can-Fite BioPharma Ltd. (CANF) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$9.8MFY2025 · since FY2016: -$8.4M → -$9.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.8M | -24.7% |
| FY2024 | -$7.9M | -3.2% |
| FY2023 | -$7.6M | +25.0% |
| FY2022 | -$10.2M | +19.4% |
| FY2021 | -$12.6M | +12.7% |
| FY2020 | -$14.4M | -14.4% |
| FY2019 | -$12.6M | -92.1% |
| FY2018 | -$6.6M | -35.7% |
| FY2017 | -$4.8M | +42.3% |
| FY2016 | -$8.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice